Controlling Hypertension and Hypotension Immediately Post Stroke (CHHIPS) - A randomised controlled trial

Health Technology Assessment

Volumn 13, Issue 9, 2009, Pages

  Potter, J ^a   Mistri, A ^b   Brodie, F ^b   Chernova, J ^b   Wilson, E ^a   Jagger, C ^b   James, M ^c   Ford, G ^d   Robinson, T ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LABETALOL; LISINOPRIL; PHENYLEPHRINE; PLACEBO; SODIUM CHLORIDE; ANTIHYPERTENSIVE AGENT; CARDIOTONIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN HEMORRHAGE; BRONCHOPNEUMONIA; BRONCHOSPASM; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISABILITY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG WITHDRAWAL; DYSPHAGIA; EVENING DOSAGE; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MORTALITY; MULTICENTER STUDY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; OXYGEN SATURATION; PATIENT COMPLIANCE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SEIZURE; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; UNITED KINGDOM; AGED; BLOOD PRESSURE; COST BENEFIT ANALYSIS; DRUG EFFECT; ECONOMICS; HOSPITAL; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; SURVIVAL; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOTONIC AGENTS; COST-BENEFIT ANALYSIS; DEGLUTITION DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HOSPITALS; HUMANS; HYPERTENSION; HYPOTENSION; INFUSIONS, INTRAVENOUS; LABETALOL; LISINOPRIL; MALE; MIDDLE AGED; PHENYLEPHRINE; PLACEBOS; STROKE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 64149114004     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta13090     Document Type: Article

References (104)

1. Bamford JM, Sandercock PAG, Hankey GJ, van Gijn J, Dennis MS, Warlow CP. Stroke: a practical guide to management. Oxford: Blackwell Scientific; 1996.
2. Martin J, Meltzer H, Elliot D. The prevalence of disability among adults. London: Office of Population Censuses and Surveys, Her Majesty's Stationery Office; 1988.
3. Isard P, Forbes J. The cost of stroke to the National Health Service in Scotland. Cerebrovasc Dis 1992;2:47-50.
4. Department of Health. The national service framework for older people. London: Department of Health; 2001.
5. Natelson B. Neurocardiology: an interdisciplinary area for the 80s. Arch Neurol 1985;42:178-84.
6. Talman W. Cardiovascular regulation and lesions of the central nervous system. Ann Neurol 1985;18:1-12.
7. Robinson TG, Waddington A, Ward-Close S, Taub N, Potter JF. The predictive role of 24-hour compared to casual blood pressure levels on outcome following acute stroke. Cerebrovasc Dis 1997;7:272.
8. Dawson SL, Manktelow BN, Robinson TG, Panerai RB, Potter JF. Which parameters of beat-to-beat blood pressure and variability best predict early outcome following acute ischaemic stroke? Stroke 2000; 31:463-8.
9. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997;349:1569-81.
10. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomized placebo-controlled trial of early aspirin use in 20000 patients with acute ischaemic stroke. Lancet 1997;349:1641-9.
11. Makatas F, Waechter R, Ebis G. Relation between cerebral perfusion pressure and arterial pressure in cerebral edema. Lancet 1972; i:684.
12. Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 2004;35:1364-7.
13. Ahmed N, Wahlgren NG. High initial blood pressure after acute stroke is associated with poor functional outcome. J Int Med 2001; 249:467-73.
14. Bhalla A, Wolfe CDA, Rudd AG. The effect of 24-h blood pressure levels on early neurological recovery after stroke. J Int Med 2001; 250:121-30.
15. Britton M, Carlsson A. Very high blood pressure in acute stroke. J Int Med 1990;228:611-15.
16. Chamorro A, Vila N, Ascaso C, Elices E, Schonewille W, Blanc R. Blood pressure and functional recovery in acute ischemic stroke. Stroke 1998;29:1850-3.
17. Dandapani BK, Suzuki S, Kelley RE, Reyes-Iglesias Y, Duncan RC. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 1995;26:21-4.
18. Davalos A, Cendra E, Teruel J, Martinez M, Genis D. Deteriorating ischemic stroke: risk factors and prognosis. Neurology 1990; 40:1865-9.
19. Dunne JW, Chakera T, Kermode S. Cerebellar haemorrhage - diagnosis and treatment: a study of 75 consecutive cases. Q J Med 1987; 245:739-54.
20. Harmsen P, Tibblin G. A stroke register in Goteborg, Sweden. Acta Med Scand 1972;191:463-70.
21. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Org 1976;54:541-52.
22. Qureshi AI, Safdar K, Weil EJ, Barch C, Bliwise DL, Colohan AR, et al. Predictors of early deterioration and mortality in Black Americans with spontaneous intracerebral hemorrhage. Stroke 1995;26:1764-7.
23. Tuhrim S, Dambrosia JM, Price TR, Mohr JP, Wolf PA, Heyman A, et al. Prediction of intracerebral hemorrhage survival. Ann Neurol 1998;24:258-63.
24. Acheson J. Factors affecting the natural history of focal cerebral vascular disease. Q J Med 1971;157:25-46.
25. Bourestom NC. Predictors of long term recovery in cerebrovascular disease. Arch Phys Med Rehabil 1967;48:415-19.
26. Robinson T, Dawson S, Ahmed U, Manktelow B, Fotherby M, Potter J. Twenty-four hour systolic blood pressure predicts long-term mortality following stroke. J Hypertens 2001;19:2127-34.
27. Wallace JD, Levy LL. Blood pressure after stroke. J Am Med Assoc 1981;246:2177-80.
28. Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 1986; 17:861-4.
29. Jansen PAF, Schulte BPM, Poels EFJ, Gribnau FWJ. Course of blood pressure after cerebral infarction and transient ischemic attack. Clin Neurol Neurosurg 1987;89:243-6.
30. Harper GD, Castleden CM, Potter JF. When can we diagnose hypertension after stroke? Age Ageing 1994;20(Suppl):P23.
31. Hoedt-Rasmussen K, Skinhoj E, Paulson O, Ewald J, Bjerrum JK, Fahrenkrug A, et al. Regional cerebral blood flow in acute apoplexy. The luxury perfusion syndrome of brain tissue. Arch Neurol 1967; 17:271-81.
32. Lassen NA. The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain. Lancet 1966;2:1113-15.
33. Fieschi C, Agnoli A, Battistini N, Bozzao L, Prencipe M. Derangement of regional blood flow and its regulatory mechanisms in acute cerebrovascular lesions. Neurology 1968;18:1166-79.
34. Eames P, Blake M, Dawson SL, Panerai R, Potter JF. Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2004; 72:467-73.
35. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Effect of blood pressure and diabetes on stroke in progression. Lancet 1994; 344:156-9.
36. Allen CMC. Predicting the outcome of acute stroke: a prognostic score. J Neurol Neurosurg Psychiatry 1984;47:475-80.
37. Merrett JD, Adams GF. Comparison of mortality rates in elderly hypertensive and normotensive hemiplegic patients. Br Med J 1966;2:802-5.
38. Osaki Y, Matsubayashi K, Yamasaki M, Okumiya K, Yoshimura K, Yoshimura K, et al. Post-stroke hypertension correlates with neurologic recovery in patients with acute ischemic stroke. Hypertens Res 1998;21:169-73.
39. Leonardi-Bee J, Bath PMW, Phillips SJ, Sandercock PAG. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002;33:1315-20.
40. Vemmos KN, Tsivgoulis G, Spengos K, Zakopoulos N, Synetos A, Manios E, et al. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern.Med 2004; 255:257-65.
41. Okumura K, Ohya Y, Maehara A, Wakugami K, Iseki K, Takishita S. Effects of blood pressure levels on case fatality after acute stroke. J Hypertens 2005;23:1217-23.
42. Coats A. Reproducibility or variability of casual and ambulatory blood pressure data: implications for clinical trials. J Hypertens 1990;6:S17-20.
43. Lindley RI, Amayo EO, Marshall J, Sandercock PAG, Dennis M, Warlow CP. Acute stroke treatment in UK hospitals: the Stroke Association survey of consultant opinion. J R Coll Phys Lond 1995;29:479-84.
44. Boiser JC, Lichtman J, Cerese J, Brass LM. Treatment of hypertension in acute ischemic stroke: the University Health Consortium Benchmarking Project. Stroke 1998;29:305.
45. Lindenauer PK, Mathew MC, Ntuli TS, Pekow PS, Fitzgerald J, Benjamin EM. Use of antihypertensive agents in the management of patients with acute ischemic stroke. Neurology 2004;63:318-23.
46. Bhalla A, Wolfe C, Rudd A. Management of blood pressure after acute stroke: a European perspective. Age Ageing 2001;30:178-9.
47. van Dellen JR, Buchanan N. Prolonged induced hypertension in the management of incipient cerebral infarction. Surg Neurol 1977; 8:185-6.
48. Vander Ark GD, Pomerantz M. Reversal of ischemic neurological signs by increasing the cardiac output. Surg Neurol 1973;1:257-8.
49. Wise G, Sutter R, Burkholder J. The treatment of brain ischemia with vasopressor drugs. Stroke 1972;3:135-40.
50. Britton M, de Faire U, Helmers C. Hazards of therapy for excessive hypertension in acute stroke. Acta Med Scand 1980; 207:253-7.
51. Lavin P. Management of hypertension in patients with acute stroke. Arch Intern Med 1986;146:66-8.
52. Blood Pressure in Acute Stroke Collaboration (BASC). Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev 2004;3. CD000039.
53. Barer DH, Cruickshank JM, Ebrahim SB, Mitchell JRA. Low dose β blockade in acute stroke ('BEST' trial): an evaluation. Br Med J 1988; 296:737-41.
54. Ahmed N, Nasman P, Wahlgren NG. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 2000; 31:1250-5.
55. Azcona A, Lataste X. Isradipine in patients with acute ischaemic cerebral infarction. Drugs 1990;40:52-7.
56. Limberg M, Hijdra A. Flunarizine in acute ischemic stroke. Eur Neurol 1990;30:121-2.
57. Norris J, LeBrun LH, Anderson BA. Intravenous nimodipine in acute ischaemic stroke. Cerebrovasc Dis 1994;4:194-6.
58. Eames P, Panerai R, Potter J, Robinson T. Bendrofluazide does not reduce arterial blood pressure in the acute stroke period. 6th Stroke Association Scientific Meeting Conference Proceedings, 2001.
59. Bath PMW, Pathansali R, Iddenden R, Bath FJ. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc Dis 2004; 11:265-72.
60. Butterworth RJ, Cluckie A, Jackson SHD, Buxton-Thomas M, Bath PMW. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis 1998; 8:158-65.
61. Rashid P, Leonardi-Bee J, Weaver C, Bath F, Bath P. The effect of transdermal glyceryl trinitrate on blood pressure and middle cerebral artery velocity in acute stroke. Cerebrovasc Dis 2002; 13:53.
62. Stokes G, Ryan M, Brnabic A, Nyberg G. A controlled study of the effects of isosorbide mononitrate on arterial blood pressure and pulse wave form in systolic hypertension. J Hypertens 1999;17:1767-73.
63. Lisk DR, Grotta JC, Lamki LM, Tran HD, Taylor JO, Molony DA, et al. Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol 1993;50:855-62.
64. Dyker AG, Grosset DG, Lees K. Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke. Stroke 1997;28:580-3.
65. Walters MR, Dyker AG, Lees KR. The effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease. Cerebrovasc Dis 2000;10:75.
66. Eveson DJ, Robinson TG, Potter JF. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up. Am J Hypertens 2007;20:270-7.
67. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-41.
68. Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, Rangoonwala B, et al. Use of ramipril in preventing stroke: double blind randomised trial. Br Med J 2002;324:699-702.
69. Schrader J, Rothemeyer M, Luders S, Kollmann K. Hypertension and stroke - rationale behind the ACCESS trial. Basic Res Cardiol 1999; 93:69-78.
70. Schrader J, Luders S, Kulschewski A, Berger J, Zidek W, Treib J, et al. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003;34:1699-703.
71. Patel RV, Kertland HR, Jahns BE, Zarowitz BJ, Mlynarek ME, Fagan SC. Labetolol: response and safety in critically ill hemorrhagic stroke patients. Ann Pharmacother 1993;27:180-1.
72. Brott T, Lu M, Kothari R, Fagan SC, Frankel M, Grotta JC, et al. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke 1998;29:1504-9.
73. Cole D, Drummond J, Osborne T, Matsumura J. Hypertension and hemodilution during cerebral ischemia reduce brain injury and edema. Am J Physiol 1990;259:H211-217.
74. Drummond J, Oh Y, Cole D, Shapiro H. Phenylephrine-induced hypertension reduces ischemia following middle cerebral artery occlusion in rats. Stroke 1989;20:1538-44.
75. Tranmer B, Gross C, Keller T, Kindt G. Acute middle cerebral artery occlusion: experience with volume expansion therapy. Neurosurgery 1986;18:397-401.
76. Duke B, Breeze R, Rubenstein D, Tranmer B, Kindt G. Induced hypervolemia and inotropic support for acute cerebral arterial insufficiency: an underused therapy. Surg Neurol 1998;49:51-7.
77. Rordorf G, Koroshetz W, Ezzeddine M, Segal A, Buonanno F. A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology 2001;56:1210-13.
78. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of induced hypertension on intracranial pressure and flow velocities of the middle cerebral arteries in patients with large hemispheric stroke. Stroke 2002;33:998-1004.
79. Mistri AK, Robinson TG, Potter JF. Pressor therapy in acute ischemic stroke: systematic review. Stroke 2006;37:1565-71.
80. Koenig MA, Geocadin RG, de Grouchy M, Glasgow J, Vimal S, Restrepo L, et al. Safety of induced hypertension therapy in patients with acute ischemic stroke. Neurocrit Care 2006;4:3-7.
81. Brott T, Adams HP, Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-70.
82. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 2007;38:1091-6.
83. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-6.
84. Duncan P, Lai S, Keighley J. Defining post-stroke recovery: implications for design and interpretation of drug trials. Neuropharmacology 2000;39:835-41.
85. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-108.
86. Department of Health. National schedule of reference costs 2005. URL: www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH_4133221.
87. HM Treasury. Green book, Annex 2. URL: http://greenbook.treasury.gov.uk. Accessed 15 October 2008.
88. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004;363:1925-33.
89. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial - Italy (MAST-I) Group. Lancet 1995;346:1509-14.
90. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Stroke 1997;28:1530-40.
91. COSSACS Trial Group. COSSACS (Continue or Stop post-Stroke Antihypertensives Collaborative Study): rationale and design. J Hypertens 2005;23:455-8.
92. Bath P, Willmot M, Weaver C, Leiardi-Bee J. Efficacy of nitric oxide in stroke (ENOS) trial - a prospective randomized controlled trial in acute stroke. Cerebrovasc Dis 2002;13(Suppl. 3):79.
93. Horn J, de Haan RJ, Vermeulen M, Limburg M. Very Early Nimodipine Use in Stroke (VENUS): a randomized, double-blind, placebo-controlled trial. Stroke 2001;32:461-5.
94. Carter AM, Catto AJ, Mansfield MW, Bamford JM, Grant PJ. Predictive variables for mortality after acute ischemic stroke. Stroke 2007;38:1873-80.
95. Harper G, Castleden CM, Potter JF. Factors affecting changes in blood pressure after acute stroke. Stroke 1994;25:1726-9.
96. Muir KW, Lees KR, Ford I, Davis S. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 2004;363:439-45.
97. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke 1999;30:793-9.
98. McInnes G, Burke TA, Carides G. Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention for Endpoint reduction in hypertension (LIFE) study. J Hum Hypertens 2006; 20:51-8.
99. Lundkvist J, Ekman M, Kartman B, Carlsson J, Jonsson L, Lithell H. The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: results from the Study on COgnition and Prognosis in the Elderly. J Hum Hypertens 2005; 19:569-76.
100. Lindgren P, Buxton M, Kahan T, Poulter N, Dahlof B, Sever P, et al. Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial - lipid-lowering arm (ASCOT-LLA). Eur J Cardiovasc Prev Rehabil 2005;12:29-36.
101. Bowen J, Yaste C. Effect of a stroke protocol on hospital costs of stroke patients. Neurology 1994;44:1961-4.
102. Diringer MN, Edwards DF, Mattson DT, Akins PT, Sheedy CW, Hsu CY, et al. Predictors of acute hospital costs for treatment of ischemic stroke in an academic center. Stroke 1999;30:724-8.
103. Adams HP, Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-711.
104. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007; 38:2001-23.